BeStock  
Stocks › ROIV

Roivant Sciences ROIV

US equityMarket cap rank #476
$36.38 −$0.19 (-0.52%)
Market open · Oct 1, 11:50 am ET · After hours $36.43 -0.38%
Open$36.35
Prev close$36.57
Day range$36.15 – $36.79
Volume728.7K
Market cap$26.28B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q1, ended Jun 2026

Revenue$1.44M-33.5% YoY
Operating profit-$366.39M-28.6% YoY
Net profit-$290.61M-6.1% YoY
Diluted EPS-$0.26+21.2% YoY
Free cash flow-$270.92M-30.0% YoY
Operating cash flow-$270.50M

Revenue, last 8 quarters

$4.5MSep '24$9.0MDec '24$7.6MMar '25$2.2MJun '25$1.6MSep '25$2.0MDec '25$2.5MMar '26$1.4MJun '26

Net profit, last 8 quarters

$-279.9MSep '24$118.1MDec '24$-252.4MMar '25$-273.9MJun '25$-166.0MSep '25$-313.7MDec '25$355.7MMar '26$-290.6MJun '26

Diluted EPS by quarter

-0.31Sep '240.23Dec '24-0.29Mar '25-0.33Jun '25-0.17Sep '25-0.38Dec '250.28Mar '26-0.26Jun '26

Free cash flow by quarter

$-267.8MSep '24$-209.1MDec '24$-173.4MMar '25$-208.4MJun '25$-193.5MSep '25$-191.5MDec '25$-165.1MMar '26$-270.9MJun '26

Annual revenue

$23.8MFY21$55.3MFY22$31.5MFY23$32.7MFY24$29.1MFY25$8.3MFY26

Profitability & balance sheet

Gross margin81.2%
Operating margin-18,146.1%
Net margin-3,535.0%
Return on equity-6.2%
Return on assets-5.2%
Return on invested capital-8.9%
Current ratio16.72
Liabilities / assets7.2%
Cash & investments$3.84B
Total debt$94.77M
Net cash (debt)$3.75B

Income statement

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Revenue as Reported $1.44M $8.26M $2.52M $2.00M $1.57M
Total Operating Revenue $1.44M $8.26M $2.52M $2.00M $1.57M
Cost of Revenue $284,000.00 $1.29M $320,000.00 $700,000.00 $111,000.00
Gross Profit $1.16M $6.98M $2.20M $1.30M $1.46M
Operating Expense $367.54M $1.29B $357.20M $340.45M $307.69M
Selling and Admin Expenses $165.53M $610.47M $158.25M $175.07M $143.13M
-General & Admin Expense $165.53M $610.47M $158.25M $175.07M $143.13M
Research & Development $202.02M $681.81M $198.95M $165.38M $164.57M
Operating Profit -$366.39M -$1.29B -$355.00M -$339.15M -$306.23M
Net Non-Operating Interest Income (Expense) $36.92M $178.11M $41.18M $43.27M $45.34M
Non-Operating Interest Income $36.92M $178.11M $41.18M $43.27M $45.34M
Other Income (Expense) $34.90M $842.62M $767.91M $5.52M $101.85M
Gain on Sale of Security $36.64M $105.05M -$25.92M $21.59M $128.50M
Special Income (Charges) $392,000.00 $781.26M $781.26M $0.00 $0.00
-Less:Other Special Charges -$392,000.00 -$770.24M – – –
Other Non-Operating Income (Expenses) -$2.13M -$43.69M $12.57M -$16.07M -$26.65M
Pretax Profit -$294.56M -$264.58M $454.10M -$290.37M -$159.04M
Tax -$3.96M $133.33M $98.35M $23.33M $7.00M
Net Profit -$290.61M -$397.91M $355.74M -$313.70M -$166.04M
Profit from Continuing Operations -$290.61M -$397.91M $355.74M -$313.70M -$166.04M
Minority Interests -$100.77M -$98.14M $52.75M -$47.81M -$52.52M
Net Income to Parent Company -$189.84M -$299.77M $302.99M -$265.89M -$113.52M
Net Income to Common Stockholders -$189.84M -$299.77M $302.99M -$265.89M -$113.52M
Basic EPS -$0.26 -$0.43 $0.43 -$0.38 -$0.17
Diluted EPS -$0.26 -$0.54 $0.28 -$0.38 -$0.17
-Gain on Sale Of Business – $11.03M $11.03M $0.00 $0.00
Net Income from Discontinuous Operations – $0.00 $0.00 $0.00 $0.00

Balance sheet

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Assets $5.31B $5.71B $5.71B $5.23B $5.06B
Total Current Assets $4.74B $5.17B $5.17B $4.66B $4.51B
Cash and Cash Equivalents & Short-Term Investments $3.84B $4.29B $4.29B $4.53B $4.39B
-Cash and Cash Equivalents $1.25B $1.42B $1.42B $1.48B $1.24B
-Short Term Investments $2.59B $2.87B $2.87B $3.05B $3.15B
Receivables $771.63M $770.24M $770.24M – –
-Other Receivables $771.63M $770.24M $770.24M – –
Other Current Assets $128.37M $105.32M $105.32M $129.91M $125.81M
Total Non-Current Assets $564.41M $541.30M $541.30M $565.48M $550.95M
Net PPE $90.21M $92.40M $92.40M $97.01M $110.80M
-Gross PPE $90.21M $92.40M $92.40M $97.01M $110.80M
Investments and Advances $444.62M $407.99M $407.99M $433.91M $412.32M
Other Non-Current Assets $29.59M $40.92M $40.92M $34.56M $27.83M
Total Liabilities $384.62M $416.28M $416.28M $251.14M $257.14M
Total Current Liabilities $283.60M $281.24M $281.24M $151.96M $133.86M
Payables $99.27M $63.69M $63.69M $20.46M $15.06M
-Accounts Payable $25.08M $18.00M $18.00M $13.29M $15.06M
-Total Tax Payable $74.18M $45.69M $45.69M $7.17M –
Current Accrued Expenses $127.92M $118.50M $118.50M $79.88M $81.95M
Short-Term Debt and Capital Lease Obligation $12.38M $11.15M $11.15M $10.44M $9.00M
-Current Capital Lease Obligation $12.38M $11.15M $11.15M $10.44M $9.00M
Other Current Liabilities $3.21M $583,000.00 $583,000.00 $26,000.00 $1.48M
Total Non-Current Liabilities $101.02M $135.03M $135.03M $99.18M $123.28M
Long Term Accounts Payable and Other Payables $0.00 $38.67M $38.67M – –
Long Term Debt and Capital Lease Obligation $94.77M $96.29M $96.29M $98.50M $89.84M
-Long Term Capital Lease Obligation $94.77M $96.29M $96.29M $98.50M $89.84M
Other Non-Current Liabilities $6.25M $70,000.00 $70,000.00 $677,000.00 $33.44M
Total Equity $4.92B $5.29B $5.29B $4.97B $4.81B
Stockholders' Equity $4.23B $4.53B $4.53B $4.27B $4.36B
Capital Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $5.13B $5.02B $5.02B $4.94B $4.77B
Retained Earnings -$900.35M -$501.81M -$501.81M -$695.00M -$429.11M
Gains/Losses Not Affecting Retained Earnings $701,000.00 $4.36M $4.36M $20.61M $19.56M
Minority Interests $690.60M $765.04M $765.04M $704.97M $443.13M
Current Deferred Liabilities – – – $3.05M –

Cash flow

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Operating Cash Flow -$270.50M -$750.35M -$163.82M -$196.48M -$185.66M
Net cash flow from continuing operations -$270.50M -$750.35M -$163.82M -$196.48M -$185.66M
Net Income from Continuing Operations -$290.61M -$397.91M $355.74M -$313.70M -$166.04M
Depreciation & Depletion & Amortization $600,000.00 $3.35M $638,000.00 $691,000.00 $921,000.00
Other Non-Cash Items $11.18M $57.81M $25.95M $10.91M $5.59M
Change in Working Capital -$32.70M -$621.80M -$601.08M $9.37M $7.08M
-Change in Receivables -$1.39M -$770.24M – – –
-Change in Payables and Accrued Expense -$16.98M $147.79M $164.43M $4.59M $18.51M
-Change in Other Current Assets -$21.97M $4.04M $11.04M -$2.73M -$1.45M
-Change in Other Current Liabilities $7.64M -$3.39M -$1.28M -$786,000.00 -$6.71M
Net cash flow from investing $281.26M -$682.33M $173.49M $109.47M $120.42M
Net Cash Flow from Continuing Investing Activities $281.26M -$682.33M $173.49M $109.47M $120.42M
Net PPE Purchase and Sale -$419,000.00 -$8.21M -$1.26M $4.94M -$7.85M
Net Investment Purchase and Sale $281.68M -$667.19M $179.17M $107.05M $128.27M
Financing Cash Flow -$181.51M $134.24M -$68.78M $328.19M $62.59M
Net Cash Flow from Continuing Financing Activities -$181.51M $134.24M -$68.78M $328.19M $62.59M
Net Common Stock Issuance -$206.73M -$125.90M -$111.21M $193.61M $0.00
Proceeds from Stock Option Exercised $76.65M $269.51M $51.19M $119.20M $69.07M
Net Other Financing Charges -$51.44M -$9.37M -$8.75M $15.39M -$6.48M
Ending Cash Balance $1.26B $1.43B $1.43B $1.49B $1.25B
Net Change in Cash -$170.75M -$1.30B -$59.10M $241.18M -$2.66M
Beginning Cash Balance $1.43B $2.73B $1.49B $1.25B $1.25B
Effect of Exchange Rate Changes $315,000.00 $3.77M $1.32M $430,000.00 $1.21M
Free Cash Flow -$270.92M -$758.56M -$165.08M -$191.55M -$193.51M
Gain/Loss from Continuing Operations – -$12.00M -$11.66M – –
Net Business Purchase and Sale – -$4.42M -$4.42M $0.00 –
Net Other Investing Changes – -$2.52M $0.00 – –
Net Issuance Payments Of Debt – $0.00 $0.00 $0.00 –
-Change In Other Working Capital – – – $8.30M –

Discussion

No comments yet — be the first to weigh in on ROIV.

Leave a comment

Scroll to Top